ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The Minafin Group has acquired a highly potent active pharmaceutical ingredient and controlled substance manufacturing facility from Ajinomoto OmniChem in Louvain-la-Neuve, Belgium, for an undisclosed sum. The site will be established as a division of the French firm’s Minakem pharmaceutical chemicals business. Minakem will operate an amino acid blending facility exclusively for Ajinomoto and employ 110 workers at the site.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X